177 related articles for article (PubMed ID: 21628799)
41. A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6.
Yasuda H; Oh CD; Chen D; de Crombrugghe B; Kim JH
J Biol Chem; 2017 Jan; 292(2):528-538. PubMed ID: 27881681
[TBL] [Abstract][Full Text] [Related]
42. [Cbfal's effect on chondrogenic gene expression in fibroblast].
Zhang W; Zhu YP; Wang J; Deng LF
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1129-32. PubMed ID: 16029574
[TBL] [Abstract][Full Text] [Related]
43. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
[TBL] [Abstract][Full Text] [Related]
44. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse.
Ng LJ; Wheatley S; Muscat GE; Conway-Campbell J; Bowles J; Wright E; Bell DM; Tam PP; Cheah KS; Koopman P
Dev Biol; 1997 Mar; 183(1):108-21. PubMed ID: 9119111
[TBL] [Abstract][Full Text] [Related]
45. Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9.
Tsuda M; Takahashi S; Takahashi Y; Asahara H
J Biol Chem; 2003 Jul; 278(29):27224-9. PubMed ID: 12732631
[TBL] [Abstract][Full Text] [Related]
46. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9.
Xie WF; Zhang X; Sakano S; Lefebvre V; Sandell LJ
J Bone Miner Res; 1999 May; 14(5):757-63. PubMed ID: 10320524
[TBL] [Abstract][Full Text] [Related]
47. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
[TBL] [Abstract][Full Text] [Related]
48. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
[TBL] [Abstract][Full Text] [Related]
49. THRAP3 interacts with and inhibits the transcriptional activity of SOX9 during chondrogenesis.
Sono T; Akiyama H; Miura S; Deng JM; Shukunami C; Hiraki Y; Tsushima Y; Azuma Y; Behringer RR; Matsuda S
J Bone Miner Metab; 2018 Jul; 36(4):410-419. PubMed ID: 28770354
[TBL] [Abstract][Full Text] [Related]
50. Fibulin-3 negatively regulates chondrocyte differentiation.
Wakabayashi T; Matsumine A; Nakazora S; Hasegawa M; Iino T; Ota H; Sonoda H; Sudo A; Uchida A
Biochem Biophys Res Commun; 2010 Jan; 391(1):1116-21. PubMed ID: 20005202
[TBL] [Abstract][Full Text] [Related]
51. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
[TBL] [Abstract][Full Text] [Related]
52. Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription.
Amano K; Hata K; Muramatsu S; Wakabayashi M; Takigawa Y; Ono K; Nakanishi M; Takashima R; Kogo M; Matsuda A; Nishimura R; Yoneda T
Mol Biol Cell; 2011 Apr; 22(8):1300-11. PubMed ID: 21346191
[TBL] [Abstract][Full Text] [Related]
53. SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer.
Aza-Carmona M; Shears DJ; Yuste-Checa P; Barca-Tierno V; Hisado-Oliva A; Belinchón A; Benito-Sanz S; RodrÃguez JI; Argente J; Campos-Barros A; Scambler PJ; Heath KE
Hum Mol Genet; 2011 Apr; 20(8):1547-59. PubMed ID: 21262861
[TBL] [Abstract][Full Text] [Related]
54. Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice.
Akiyama H; Stadler HS; Martin JF; Ishii TM; Beachy PA; Nakamura T; de Crombrugghe B
Matrix Biol; 2007 May; 26(4):224-33. PubMed ID: 17222543
[TBL] [Abstract][Full Text] [Related]
55. [Molecular mechanisms of cartilage formation and chondrocyte maturation].
Tamamura Y; Iwamoto M
Clin Calcium; 2004 Jul; 14(7):15-21. PubMed ID: 15577071
[TBL] [Abstract][Full Text] [Related]
56. The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner.
Yano F; Kugimiya F; Ohba S; Ikeda T; Chikuda H; Ogasawara T; Ogata N; Takato T; Nakamura K; Kawaguchi H; Chung UI
Biochem Biophys Res Commun; 2005 Aug; 333(4):1300-8. PubMed ID: 15979579
[TBL] [Abstract][Full Text] [Related]
57. Synergistic co-regulation and competition by a SOX9-GLI-FOXA phasic transcriptional network coordinate chondrocyte differentiation transitions.
Tan Z; Niu B; Tsang KY; Melhado IG; Ohba S; He X; Huang Y; Wang C; McMahon AP; Jauch R; Chan D; Zhang MQ; Cheah KSE
PLoS Genet; 2018 Apr; 14(4):e1007346. PubMed ID: 29659575
[TBL] [Abstract][Full Text] [Related]
58. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.
Han Y; Lefebvre V
Mol Cell Biol; 2008 Aug; 28(16):4999-5013. PubMed ID: 18559420
[TBL] [Abstract][Full Text] [Related]
59. [Vascular calcification].
Shioi A
Clin Calcium; 2004 Jun; 14(6):38-41. PubMed ID: 15577052
[TBL] [Abstract][Full Text] [Related]
60. [Cartilage and mechanical stress from the point of the view of development, growth, pathology and therapeutic aspects].
Fujisawa T; Takigawa M; Kuboki T
Clin Calcium; 2004 Jul; 14(7):29-35. PubMed ID: 15577073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
